clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
AI Models Outperformed Human Experts in Detecting Ovarian Cancer on Ultrasound
Informatics
Large-Scale Genomic Analysis Improves Outcomes in 20 Cancer Types
News & Features
New Genetic Variants May Help Explain Why More Boys Get Autism
News & Features
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Informatics
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Whose Genes Anyway?: Congressional action on Section 101 of U.S. patent law could reopen path to patenting genes
Drug development (Pharmacology)
News & Features
Whose Genes Anyway?: Congressional action on Section 101 of U.S. patent law could reopen path to patenting genes
Chris Anderson
July 18, 2019
0
Molecular Dx
NIPT Startup Cradle Genomics Closes $17.1M Series A Financing
July 16, 2019
0
News & Features
We Have the Tools to Advance Precision Medicine, Why Aren’t We Using Them?
David Massina, Ph.D.
April 2, 2019
0
News & Features
New Focus on Genomics: Konica Minolta Builds Its Presence in Precision Medicine via Acquisitions
Alex Philippidis
November 6, 2018
0
Informatics
IQVIA, Genomics England Partner on Platform Integrating Clinical, Genomic Data
October 4, 2018
0
News & Features
Allison, Honjo Share Nobel Prize for Immunotherapy Breakthroughs
October 1, 2018
0
Molecular Dx
Broad Institute, Bayer Partner on Precision Medicine for Heart Failure
June 29, 2018
0
Molecular Dx
Disruptive Research
Alex Philippidis
April 9, 2018
0
News & Features
Vantari Genetics, Translational Software to Support Banner Alzheimer’s Institute’s GeneMatch
Alex Philippidis
October 25, 2017
0
News & Features
Cepheid, MedImmune Join COMBACTE in Antibacterial Diagnostics Collaboration
January 14, 2016
0
1
...
9
10
11
Page 10 of 11
Related Content
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Study Suggests Cytomegalovirus Could Contribute to Alzheimer's Pathology in Certain Individuals
Mutated Cilia Implicated in Pathology of ALS
Not All Precision Medicine Heroes Wear Lab Coats
Inside Precision Medicine
![IQVIA will partner with Genomics England to develop a platform designed to allow researchers to create custom clinical-genomic datasets and run advanced analytics on genomics and observable traits by combining IQVIA’s E360 healthcare analytics platform (pictured) with Genomics England’s patient data. [Source: IQVIA]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1925-768x273.jpeg "IQVIA, Genomics England Partner on Platform Integrating Clinical, Genomic Data")
